Literature DB >> 23681307

Association between GSTM1 and CYP1A1 polymorphisms and survival in oral cancer patients.

Deepika Shukla1, Alka Dinesh Kale, Seema Hallikerimath, Venkatakanthaiah Yerramalla, Vivekanandhan Subbiah, Shashwat Mishra.   

Abstract

AIMS: Cancer patient's inherited genotype may influence his or her survival, but evidence for the role of these genetic differences in oral cancer survival has not yet been explored.
METHODS: The authors evaluated polymorphisms in the GSTM1 and CYP1A1 genes for associations with overall survival in 100 oral squamous cell carcinoma (OSCC) treated patients and 100 controls who were followed up for survival within 2 years of the date of completion of their treatment. Overall survival was evaluated in Kaplan-Meier survival functions and Cox proportional hazards models.
RESULTS: After adjustment for stage and histology, GSTM1null genotype was associated with shorter survival among OSCC patients, compared with GSTM1 present genotype. There was no association between CYP1A1 C genotype and survival in the overall study population.
CONCLUSION: The study indicated a potential role for GSTM1 polymorphism in predicting the clinical outcomes of treated oral carcinoma patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23681307     DOI: 10.5507/bp.2013.028

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  7 in total

1.  CYP1A1 MspI polymorphism and the risk of oral squamous cell carcinoma: Evidence from a meta-analysis.

Authors:  Shang Xie; Chongdai Luo; Xiaofeng Shan; Shushan Zhao; Jing He; Zhigang Cai
Journal:  Mol Clin Oncol       Date:  2016-02-05

Review 2.  CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study.

Authors:  Sumaira Akhtar; Ishrat Mahjabeen; Zertashia Akram; Mahmood Akhtar Kayani
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

3.  Association of CYP1A1 and GSTM1 Polymorphisms With Oral Cancer Susceptibility: A Meta-Analysis.

Authors:  Haitao Liu; Jinlin Jia; Xuemei Mao; Zhiyong Lin
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

4.  Involvement of cytochrome P450 1A1 and glutathione S-transferase P1 polymorphisms and promoter hypermethylation in the progression of anti-tuberculosis drug-induced liver injury: a case-control study.

Authors:  Lei He; Li Gao; Zhe Shi; Yuhong Li; Lingyan Zhu; Shiming Li; Peng Zhang; Guoying Zheng; Qi Ren; Yun Li; Bo Hu; Fumin Feng
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

5.  Correlation of CpG Island Methylation of the Cytochrome P450 2E1/2D6 Genes with Liver Injury Induced by Anti-Tuberculosis Drugs: A Nested Case-Control Study.

Authors:  Jinling Zhang; Xuebin Zhu; Yuhong Li; Lingyan Zhu; Shiming Li; Guoying Zheng; Qi Ren; Yonghong Xiao; Fumin Feng
Journal:  Int J Environ Res Public Health       Date:  2016-08-01       Impact factor: 3.390

6.  GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms in outcomes of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation.

Authors:  Eder C Pincinato; Ericka F D Costa; Leisa Lopes-Aguiar; Guilherme A S Nogueira; Tathiane R P Lima; Marília B Visacri; Anna P L Costa; Gustavo J Lourenço; Luciane Calonga; Fernanda V Mariano; Albina M A M Altemani; Cláudia Coutinho-Camillo; Carlos T Chone; Celso D Ramos; João M C Altemani; Patrícia Moriel; Carmen S P Lima
Journal:  Sci Rep       Date:  2019-06-27       Impact factor: 4.379

7.  Association between the CYP1A1 MspI polymorphism and risk of head and neck cancer: a meta-analysis.

Authors:  Hady Mohammadi; Mehrnoush Momeni Roochi; Farzad Rezaei; Ata Garajei; Hosein Heidar; Bayazid Ghaderi; Masoud Sadeghi
Journal:  Sci Rep       Date:  2022-01-27       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.